Thursday February 27, 2020

Glanbia poised for growth through American acquisition

Glanbia is buoyant after another year of strong growth and can make more moves in the growing performance nutrition market, writes Michael Murray.

16th March, 2014
Recipe for success Siobhan Talbot, Glanbia managing director, and Mark Garvey, financial director. Picture: Jason Clarke Photography

CytoSport, the US-based sports nutrition business, remains a potential takeover target for Glanbia as the bidding process for the US company remains a work in progress.

Following its results announcement last week Glanbia group managing director Siobhán Talbot said that any decision to raise new equity would be ''event driven. This followed reports - in circulation since last summer - that the performance nutrition and ingredients group is on a shortlist of potential buyers for...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 1 month ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago